Table 4.
Association between risk haplotype and salivary biomarkers.
OR (95% CI) for periodontitis risk haplotype, P value |
|||
---|---|---|---|
Model 1a | Model 2a | Model 3a | |
PLTP (nmol/h/ml)b | 1.194 (0.950–1.502), 0.129 | 1.195 (0.949–1.505), 0.129 | 1.197 (0.948–1.512), 0.130 |
LTA (pg/ml)b | 0.962 (0.880–1.050), 0.383 | 0.967 (0.884–1.058), 0.467 | 0.974 (0.890–1.067), 0.572 |
IL-8 (pg/ml)b | 1.155 (0.878–1.521), 0.303 | 1.209 (0.907–1.611), 0.195 | 1.228 (0.919–1.641), 0.165 |
MPO (ng/ml)b | 1.264 (1.028–1.556), 0.027 | 1.321 (1.063–1.641), 0.012 | 1.372 (1.092–1.723), 0.007 |
CRSc | 1.793 (0.988–3.400), 0.052 | 1.831 (0.981–3.416), 0.054 | 1.807 (0.958–3.406), 0.068 |
Logistic regression model for periodontal risk haplotype in either chromosome (dominant model).
aModel 1, adjusted for number of teeth; model 2, adjusted additionally for age, gender, diabetes, smoking (never/ever); model 3, adjusted additionally for PPD.
bOR (95% CI) per unit increase of logarithmically transformed values.
cOR (95% CI) per change from low risk to moderate/high risk of having periodontitis (CRS II-III vs. I).
CI: confidence interval; CRS: cumulative risk score; LTA: lymphotoxin-α; MPO: myeloperoxidase; OR: odds ratio; PLTP: phospholipid transfer protein.
Significant P values are highlighted in bold. Analyses were performed in the Parogene population (n = 455) including patients with an indication to coronary artery angiography.